Skip to main content
. 2021 Aug 19;56(10):914–927. doi: 10.1007/s00535-021-01814-y

Fig. 1.

Fig. 1

RNA sequencing of LCN2 mRNA in colonic mucosa of collagenous colitis. a LCN2 mRNA expression in pinch biopsies from colonic mucosa of active collagenous colitis (aCC), budesonide-treated collagenous colitis with clinical remission (tCC), budesonide-refractory collagenous colitis (rCC) and healthy controls (HC). Active ulcerative colitis (aUC) was included for comparison (separated by dotted line). The y-axis shows LCN2 mRNA expression as log2 of normalized counts and the violin plots visualize distribution frequency in addition to individual values (dots), median (thick line), upper and lower quartiles (thin lines). b Paired analysis of LCN2 mRNA expression in colonic mucosa of individual patients with active collagenous colitis before (aCC) and during budesonide treatment with clinical remission (tCC). The y-axis shows LCN2 mRNA expression as log 2 of normalized counts in paired biopsies from nine individual patients. P adj = adjusted P value, ns = non-significant, *P < 0.05, ***P < 0.001, ****P < 0.0001 Analysed as described in “Materials and methods